ANIXA BIOSCIENCES, INC. Stock or Unit Option Plan Expense
ANIXA BIOSCIENCES, INC. (ANIX) reported Stock or Unit Option Plan Expense of $4.80 million for the 9-month period ending 2021-07-31, per its 10-Q filed 2021-09-01.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:StockOptionPlanExpense · last filed 2021-09-01
- ANIXA BIOSCIENCES, INC. stock or unit option plan expense for the quarter ending 2021-07-31 was $3.05M, a 205.70% increase year-over-year.
- ANIXA BIOSCIENCES, INC. stock or unit option plan expense for the quarter ending 2021-04-30 was $880.78K, a 16.54% decline year-over-year.
- ANIXA BIOSCIENCES, INC. stock or unit option plan expense for the quarter ending 2021-01-31 was $874.86K, a 9.24% decline year-over-year.
- ANIXA BIOSCIENCES, INC. stock or unit option plan expense for the quarter ending 2020-10-31 was $906.41K, a 20.54% increase year-over-year.
- ANIXA BIOSCIENCES, INC. stock or unit option plan expense for fiscal 2020 was $3.92M, a 10.16% increase from fiscal 2019.
- ANIXA BIOSCIENCES, INC. stock or unit option plan expense for fiscal 2019 was $3.56M, a 37.72% decline from fiscal 2018.
- ANIXA BIOSCIENCES, INC. stock or unit option plan expense for fiscal 2018 was $5.72M, a 368.86% increase from fiscal 2017.
- ANIXA BIOSCIENCES, INC. stock or unit option plan expense for fiscal 2017 was $1.22M, a 39.60% increase from fiscal 2016.
| Period end | Stock or Unit Option Plan Expense 3 month | Stock or Unit Option Plan Expense 6 month | Stock or Unit Option Plan Expense 9 month | Stock or Unit Option Plan Expense 12 month | Stock or Unit Option Plan Expense 12 month as first filed |
|---|---|---|---|---|---|
| 2021-07-31 | $3.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-09-01 | $3.93M derived: sum of 2 quarters · filed 2021-09-01 | $4.80M 10-Q · filed 2021-09-01 | $5.71M derived: sum of 4 quarters · filed 2021-09-01 | |
| 2021-04-30 | $880.78K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-06-10 | $1.76M 10-Q · filed 2021-06-10 | $2.66M derived: sum of 3 quarters · filed 2021-06-10 | $3.66M derived: sum of 4 quarters · filed 2021-06-10 | |
| 2021-01-31 | $874.86K 10-Q · filed 2021-03-11 | $1.78M derived: sum of 2 quarters · filed 2021-03-11 | $2.78M derived: sum of 3 quarters · filed 2021-03-11 | $3.83M derived: sum of 4 quarters · filed 2021-06-10 | |
| 2020-10-31 | $906.41K derived: 10-K 12 month − 10-Q 9 month · filed 2021-01-07 | $1.90M derived: sum of 2 quarters · filed 2021-01-07 | $2.96M derived: sum of 3 quarters · filed 2021-06-10 | $3.92M 10-K · filed 2021-01-07 | |
| 2020-07-31 | $997.00K 10-Q · filed 2020-09-08 | $2.05M derived: sum of 2 quarters · filed 2021-06-10 | $3.02M 10-Q · filed 2021-09-01 | $3.77M derived: sum of 4 quarters · filed 2021-06-10 | |
| 2020-04-30 | $1.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-06-10 | $2.02M 10-Q · filed 2021-06-10 | $2.77M derived: sum of 3 quarters · filed 2021-06-10 | $3.56M derived: sum of 4 quarters · filed 2021-06-10 | |
| 2020-01-31 | $963.88K 10-Q · filed 2021-03-11 | $1.72M derived: sum of 2 quarters · filed 2021-03-11 | $2.50M derived: sum of 3 quarters · filed 2021-03-11 | $3.30M derived: sum of 4 quarters · filed 2021-03-11 | |
| 2019-10-31 | $751.97K derived: 10-K 12 month − 10-Q 9 month · filed 2021-01-07 | $1.54M derived: sum of 2 quarters · filed 2021-01-07 | $2.34M derived: sum of 3 quarters · filed 2021-01-07 | $3.56M 10-K · filed 2021-01-07 | |
| 2019-07-31 | $784.00K 10-Q · filed 2020-09-08 | $1.59M derived: sum of 2 quarters · filed 2020-09-08 | $2.81M 10-Q · filed 2020-09-08 | $4.93M derived: sum of 4 quarters · filed 2020-09-08 | |
| 2019-04-30 | $805.10K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-06-09 | $2.02M 10-Q · filed 2020-06-09 | $4.14M derived: sum of 3 quarters · filed 2020-06-09 | $7.27M derived: sum of 4 quarters · filed 2020-06-09 | |
| 2019-01-31 | $1.22M 10-Q · filed 2020-03-09 | $3.34M derived: sum of 2 quarters · filed 2020-03-09 | $6.46M derived: sum of 3 quarters · filed 2020-03-09 | $6.72M derived: sum of 4 quarters · filed 2020-03-09 | |
| 2018-10-31 | $2.12M derived: 10-K 12 month − 10-Q 9 month · filed 2020-01-09 | $5.25M derived: sum of 2 quarters · filed 2020-01-09 | $5.50M derived: sum of 3 quarters · filed 2020-01-09 | $5.72M 10-K · filed 2020-01-09 | |
| 2018-07-31 | $3.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-09-06 | $3.38M derived: sum of 2 quarters · filed 2019-09-06 | $3.60M 10-Q · filed 2019-09-06 | $3.89M derived: sum of 4 quarters · filed 2019-09-06 | |
| 2018-04-30 | $258.11K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-06-12 | $472.53K 10-Q · filed 2019-06-12 | $759.23K derived: sum of 3 quarters · filed 2019-06-12 | $1.24M derived: sum of 4 quarters · filed 2019-06-12 | |
| 2018-01-31 | $214.43K 10-Q · filed 2019-03-13 | $501.12K derived: sum of 2 quarters · filed 2019-03-13 | $982.24K derived: sum of 3 quarters · filed 2019-03-13 | $1.17M derived: sum of 4 quarters · filed 2019-03-13 | |
| 2017-10-31 | $286.69K derived: 10-K 12 month − 10-Q 9 month · filed 2019-01-11 | $767.81K derived: sum of 2 quarters · filed 2019-01-11 | $959.73K derived: sum of 3 quarters · filed 2019-01-11 | $1.22M 10-K · filed 2019-01-11 | $1.22M 10-K · filed 2018-01-09 |
| 2017-07-31 | $481.12K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-09-07 | $673.04K derived: sum of 2 quarters · filed 2018-09-07 | $932.77K 10-Q · filed 2018-09-07 | $1.24M derived: sum of 4 quarters · filed 2018-09-07 | |
| 2017-04-30 | $191.92K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-06-11 | $451.65K 10-Q · filed 2018-06-11 | $755.03K derived: sum of 3 quarters · filed 2018-06-11 | $995.47K derived: sum of 4 quarters · filed 2018-06-11 | |
| 2017-01-31 | $259.74K 10-Q · filed 2018-03-09 | $563.11K derived: sum of 2 quarters · filed 2018-03-09 | $803.55K derived: sum of 3 quarters · filed 2018-03-09 | $1.02M derived: sum of 4 quarters · filed 2018-03-09 | |
| 2016-10-31 | $303.37K derived: 10-K 12 month − 10-Q 9 month · filed 2018-01-09 | $543.81K derived: sum of 2 quarters · filed 2018-01-09 | $761.07K derived: sum of 3 quarters · filed 2018-01-09 | $873.56K 10-K · filed 2018-01-09 | |
| 2016-07-31 | $240.44K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-09-08 | $457.69K derived: sum of 2 quarters · filed 2017-09-08 | $570.19K 10-Q · filed 2017-09-08 | $908.20K derived: sum of 4 quarters · filed 2017-09-08 | |
| 2016-04-30 | $217.25K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-05-26 | $329.75K 10-Q · filed 2017-05-26 | $667.76K derived: sum of 3 quarters · filed 2017-05-26 | $1.45M derived: sum of 4 quarters · filed 2017-05-26 | |
| 2016-01-31 | $112.50K 10-Q · filed 2017-03-16 | $450.50K derived: sum of 2 quarters · filed 2017-03-16 | $1.23M derived: sum of 3 quarters · filed 2017-03-16 | $2.30M derived: sum of 4 quarters · filed 2017-03-16 | |
| 2015-10-31 | $338.01K derived: 10-K 12 month − 10-Q 9 month · filed 2016-12-08 | $1.12M derived: sum of 2 quarters · filed 2016-12-08 | $2.18M derived: sum of 3 quarters · filed 2016-12-08 | $2.68M 10-K · filed 2016-12-08 | |
| 2015-07-31 | $780.59K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-08-19 | $1.85M derived: sum of 2 quarters · filed 2016-08-19 | $2.34M 10-Q · filed 2016-08-19 | $3.14M derived: sum of 4 quarters · filed 2016-08-19 | |
| 2015-04-30 | $1.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-05-20 | $1.56M 10-Q · filed 2016-05-20 | $2.36M derived: sum of 3 quarters · filed 2016-05-20 | $2.83M derived: sum of 4 quarters · filed 2016-05-20 | |
| 2015-01-31 | $491.78K 10-Q · filed 2016-02-19 | $1.29M derived: sum of 2 quarters · filed 2016-02-19 | $1.76M derived: sum of 3 quarters · filed 2016-02-19 | $2.92M derived: sum of 4 quarters · filed 2016-02-19 | |
| 2014-10-31 | $803.21K derived: 10-K 12 month − 10-Q 9 month · filed 2015-12-23 | $1.27M derived: sum of 2 quarters · filed 2015-12-23 | $2.43M derived: sum of 3 quarters · filed 2015-12-23 | $3.15M 10-K · filed 2015-12-23 | |
| 2014-07-31 | $469.48K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-08-18 | $1.63M derived: sum of 2 quarters · filed 2015-08-18 | $2.35M 10-Q · filed 2015-08-18 | ||
| 2014-04-30 | $1.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-05-22 | $1.88M 10-Q · filed 2015-05-22 | |||
| 2014-01-31 | $720.64K 10-Q · filed 2015-03-09 | ||||
| 2012-10-31 | $615.00K 10-K · filed 2013-01-29 | ||||
| 2011-10-31 | $742.00K 10-K · filed 2013-01-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 |